Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

ChemoMetec

400.40 DKK

-0.05 %

Less than 1K followers

CHEMM

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ChemoMetec

20192020202120222023202420252026
Revenue175.5214.1281.1427.2442.3407.4495.6
growth-%22.0 %31.3 %51.9 %3.5 %-7.9 %21.7 %
EBITDA64.992.6135.6222.9251.0186.2258.1-
EBIT54.177.5116.0202.9230.6169.0236.5-
Profit before taxes53.775.9112.7203.2230.4176.6240.0
Net income41.859.288.4159.5178.7136.3186.4-
EPS2.403.515.249.1610.277.8310.71-
Dividend13.0020.504.000.006.004.007.000.00
Dividend ratio540.6 %584.0 %76.3 %0.0 %58.4 %51.1 %65.4 %

Profitability and return on capital

20192020202120222023202420252026
EBITDA-%37.0 %43.3 %48.2 %52.2 %56.8 %45.7 %52.1 %
EBIT-%30.8 %36.2 %41.3 %47.5 %52.1 %41.5 %47.7 %
ROE24.1 %29.2 %33.3 %44.6 %33.5 %24.1 %27.7 %
ROI17.6 %22.5 %25.6 %31.8 %27.2 %20.1 %22.5 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.